Tommaso Manacorda1,2, Paolo Bandiera3, Federica Terzuoli4, Michela Ponzio5, Giampaolo Brichetto5,6, Paola Zaratin7, Daiana Bezzini8, Mario A Battaglia9. 1. Research Fellow, Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, UK. 2. Expert Advisor, Italian Multiple Sclerosis Foundation, Italy. 3. Director, Advocacy and Legal Department, Italian Multiple Sclerosis Society, Italy. 4. Project Manager, Advocacy and Legal Department, Italian Multiple Sclerosis Society, Italy. 5. Researcher, Scientific Research Area, Italian Multiple Sclerosis Foundation, Italy. 6. Clinical Director, AISM Rehabilitation Centre, Italian Multiple Sclerosis Society, Italy. 7. Research Director, Scientific Research Area, Italian Multiple Sclerosis Foundation, Italy. 8. Researcher, Department of Life Sciences, University of Siena, Italy. 9. President, Italian Multiple Sclerosis Foundation and Professor, Department of Life Sciences, University of Siena, Italy.
Abstract
OBJECTIVE: To describe the disruptions in care experienced by persons with Multiple Sclerosis in Italy due to the COVID-19 pandemic and the self-reported impact on their health and wellbeing. METHODS: A cross-sectional online survey was completed by 2722 persons with Multiple Sclerosis, after Italy instituted a national lockdown in response to the pandemic. RESULTS: Persons with Multiple Sclerosis reported that the pandemic caused broad disruptions to usual health and social care services, which impacted on their health and wellbeing. Disruptions in care were consistently associated with negative self-reported impacts on the expected progression of the disease, on out-of-pocket expenditure and on carer's stress. Psychological consequences were associated with interruption to usual psychological support, and concerns about the safety of care delivered in person. CONCLUSIONS: The quality of life of persons with Multiple Sclerosis depends greatly on prompt access to a broad range of health and care services. Negative psychological impacts reported by persons with Multiple Sclerosis with less severe disabilities show that accessible integrated services are crucial for maintenance of their wellbeing. Most persons with Multiple Sclerosis with more severe disability experienced negative impacts on perceived health. Their carers compensating for lack of social input resulted in care overburden. As continuity of care is crucial for persons with Multiple Sclerosis, as well as for persons with chronic conditions in general, strategies must be in place to ensure it is included in future pandemic response plans.
OBJECTIVE: To describe the disruptions in care experienced by persons with Multiple Sclerosis in Italy due to the COVID-19 pandemic and the self-reported impact on their health and wellbeing. METHODS: A cross-sectional online survey was completed by 2722 persons with Multiple Sclerosis, after Italy instituted a national lockdown in response to the pandemic. RESULTS:Persons with Multiple Sclerosis reported that the pandemic caused broad disruptions to usual health and social care services, which impacted on their health and wellbeing. Disruptions in care were consistently associated with negative self-reported impacts on the expected progression of the disease, on out-of-pocket expenditure and on carer's stress. Psychological consequences were associated with interruption to usual psychological support, and concerns about the safety of care delivered in person. CONCLUSIONS: The quality of life of persons with Multiple Sclerosis depends greatly on prompt access to a broad range of health and care services. Negative psychological impacts reported by persons with Multiple Sclerosis with less severe disabilities show that accessible integrated services are crucial for maintenance of their wellbeing. Most persons with Multiple Sclerosis with more severe disability experienced negative impacts on perceived health. Their carers compensating for lack of social input resulted in care overburden. As continuity of care is crucial for persons with Multiple Sclerosis, as well as for persons with chronic conditions in general, strategies must be in place to ensure it is included in future pandemic response plans.
Authors: Kottil W Rammohan; June Halper; Steven Lang; Sara McCurdy Murphy; Lisa Patton; Courtney Goodman; David K B Li Journal: Int J MS Care Date: 2021-12-29
Authors: Ana Muñoz-Jurado; Begoña M Escribano; Eduardo Agüera; Javier Caballero-Villarraso; Alberto Galván; Isaac Túnez Journal: J Neurol Date: 2022-07-05 Impact factor: 6.682
Authors: Silvia Poli; Michela Rimondini; Alberto Gajofatto; Maria Angela Mazzi; Isolde Martina Busch; Francesca Gobbin; Federico Schena; Lidia Del Piccolo; Valeria Donisi Journal: Int J Environ Res Public Health Date: 2021-04-14 Impact factor: 3.390
Authors: Peter Rieckmann; Diego Centonze; Gavin Giovannoni; Le H Hua; Celia Oreja-Guevara; Daniel Selchen; Per Soelberg Sørensen; Patrick Vermersch; Heinz Wiendl; Hashem Salloukh; Bassem Yamout Journal: Ther Adv Neurol Disord Date: 2021-12-07 Impact factor: 6.430
Authors: Yael Goverover; Michelle H Chen; Amanda Botticello; Gerald T Voelbel; Grace Kim; John DeLuca; Helen M Genova Journal: Mult Scler Relat Disord Date: 2021-10-18 Impact factor: 4.339